Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;7(9):1932-5.
doi: 10.7860/JCDR/2013/6031.3373. Epub 2013 Aug 10.

Sclerosing stromal tumour in young women: clinicopathologic and immunohistochemical spectrum

Affiliations

Sclerosing stromal tumour in young women: clinicopathologic and immunohistochemical spectrum

Ecmel Isik Kaygusuz et al. J Clin Diagn Res. 2013 Sep.

Abstract

Aim: Sclerosing stromal tumor is a benign tumor of ovary. We aimed to review the clinical findings and immunohistochemical results of SSTs through the 7 diagnosed cases in our hospital.

Material and methods: As immunohistochemical, blocks were applied with estrogen receptor , progesterone receptor, inhibin, calretinin, melan-A, CD10, smooth muscle actin, desmine, vimentin, CD34, S-100, C-kit, cytokeratin , cytokeratin7.

Results: Macroscopically, while 5 tumors had solid appearance, 2 tumors were composed of solid and cystic areas. All the tumors were in shape of ovarian masses with good limits. Microscopically, two types of cells were observed as fusiform fibroblast-like cells and theca-like cells with vacuolised cytoplasm. Immunohistochemical results: vimentin, smooth muscle actin, desmine, progesterone receptor, calretinin, inhibin were positive in all the cases; S-100, cytokeratin, cytokeratin7, estrogen receptor were negative in all the cases; CD-10 was positive in 2 cases; C-kit was positive in 5 cases; melan-A was positive in 4 cases.

Conclusions: The significance of these tumors is that it is necessary to distinguish the histopathology in the frozen section in order to protect the other adnexa because of the characteristics to be observed at early ages (2(nd) and 3(rd) decades). Our findings support the conclusion that sclerosing stromal tumors are benign-character tumors that stem from over stroma and are hormonally active tumors because of the detected clinical and immunohistochemical results, although no hormonal effect that could be supported with laboratory tests was observed.

Keywords: Immunohistochemistry; Ovary; Sclerosing.

PubMed Disclaimer

Figures

[Table/Fig-2]:
[Table/Fig-2]:
Inhibin positive cells
[Table/Fig-3]:
[Table/Fig-3]:
Calretinine positive cells
[Table/Fig-4]:
[Table/Fig-4]:
Melan-A positive cells

References

    1. Chalvardjian A, Scully RE. Sclerosing stromal tumor of the ovary. Cancer. 1973;31:664–70. - PubMed
    1. Hsu C, Ma L, Mak L. Sclerosing stromal tumor of the ovary: case report and review of the literature. Int J Gynecol Pathol. 1983;2:192–200. - PubMed
    1. Quinn MA, Oster AO, Fortune D, Hudson B. Sclerosing stromal tumor of the ovary: case report with endocrine studies. Br J Obstet Gynecol. 1981;88:555–58. - PubMed
    1. Tsukamoto N, Nakamura M, Ishikawa H. Sclerosing stromal tumor of the ovary. Gynecol Oncol. 1976;4:335–39. - PubMed
    1. Tiltman AJ. Sclerosing stromal tumor of the ovary. Int J Gynecol Pathol. 1985;4:362–69. - PubMed

LinkOut - more resources